Medication info
Telmisartan Hydrochlorothiazide Plus Tablet 40/12.5 mg

Telmisartan Hydrochlorothiazide Plus Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 201803030 · Approved 2018.07.20 · Insurance code 698503900

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this fixed-dose combination, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be used in patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be used in patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be used in patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered separately or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension. It is added to patients who have difficulty controlling blood pressure solely with Telmisartan to help effectively lower and control blood pressure.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this fixed-dose combination, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be used in patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be used in patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be used in patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered separately or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used in pregnant women as it can lead to serious problems for the fetus or newborn, especially during the 2nd and 3rd trimester. It should not be administered to patients with allergies to certain components, severely impaired liver or kidney function, or those with obstructive biliary diseases. Caution is required when using this medication in the elderly or in patients with elevated potassium levels, or liver dysfunction. Although this medication lowers blood pressure, side effects such as dizziness, hypotension, electrolyte imbalance, liver dysfunction, and skin rashes may occur. In particular, the diuretic component of this medication may alter electrolyte balance, increasing the risk of hypokalemia, hyperkalemia, and hyponatremia, so regular blood tests are necessary. This medication may interact with other antihypertensive drugs, lithium, potassium supplements, non-steroidal anti-inflammatory drugs, etc., so consultation with a doctor or pharmacist is essential. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should also avoid it if possible. In case of overdose, it can lead to hypotension, arrhythmias, electrolyte imbalances, and dehydration, so contact a medical facility immediately. This medication is not recommended for use in children under 18 years as safety and efficacy have not been established. Drowsiness or dizziness may occur while taking this medication, so caution is advised when driving or operating dangerous machinery. This medication should be stored away from direct sunlight and out of reach of children, and it is important to take it immediately after removing it from the packaging.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 130 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • indigestion
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • pain in bones
  • kidney dysfunction
  • asthenia
  • increased creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudate
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • pancreatitis
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute kidney failure
  • diabetes
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floaters
  • lip and hand tremors
  • sensory hypersensitivity
  • gum disease
  • chapped lips
  • vision deterioration
  • hypotension
  • tachycardia
  • bradycardia
  • hypokalemia
  • hyponatremia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps
  • cardiac arrhythmia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperature at room temperature between 1 degree and 30 degrees Celsius. This will help preserve the effectiveness and safety of the medication for a long time.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.